NIBEC Co., Ltd.
Research NIBEC Co., Ltd. (138610.KQ) on Bullrun: market cap KRW 171.65B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker138610.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 171.65B
- Financial periodQ2 2026
- RevenueKRW 6.06B
- Net incomeKRW 381.34M
- Free cash flow-KRW 1.61B
- Gross margin57.2%
Valuation Snapshot
latest market cap is KRW 171.65B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 171.65B | n/a | n/a | n/a |
Dividend history
About NIBEC Co., Ltd.
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is based in Jincheon-eup, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NIBEC Co., Ltd.'s market cap?
NIBEC Co., Ltd.'s market capitalization is KRW 171.65B.
What does NIBEC Co., Ltd. do?
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is based in Jincheon-eup, South Korea.